乐观
$30.22
情景价格
$25.500
-0.237 (-0.93%)收盘时
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
Philips NV (PHG) appears to be a good buy right now due to its strong financial indicators and positive market sentiment. The stock has shown a 5-day change of +6.19%, and its gross margin has improved to 49.31% in Q2 2026, indicating efficient cost management and profitability. However, a key risk is the significant selling pressure from hedge funds, which has increased by 30126.47% over the last quarter, suggesting potential volatility ahead.
Morgan Stanley
—
2026-09-11
Morgan Stanley
2026-09-11
目标价
—
UBS
—
2026-08-03
UBS
2026-08-03
目标价
—
Deutsche Bank
—
2026-07-30
Deutsche Bank
2026-07-30
目标价
—
JPMorgan
—
2026-07-29
JPMorgan
2026-07-29
目标价
—
Citi
—
2026-07-01
Citi
2026-07-01
目标价
—
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

EXIT-CVD Project Launched to Enhance Cardiovascular Health

Philips Establishes Global Clinical Advisory Board for Oral Healthcare

Philips Launches Smart Toothbrush to Enhance Oral Care Experience

Philips Launches New CT System to Enhance Emergency Imaging Services

Philips Partners with Red Bull to Showcase Individuality
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others. It operates in the Healthcare sector.
Philips NV (PHG) appears to be a good buy right now due to its strong financial indicators and positive market sentiment. The stock has shown a 5-day change of +6.19%, and its gross margin has improved to 49.31% in Q2 2026, indicating efficient cost management and profitability. However, a key risk is the significant selling pressure from hedge funds, which has increased by 30126.47% over the last quarter, suggesting potential volatility ahead.
1 analysts cover PHG: 1 rate it Buy, 0 Hold and 0 Sell.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。